EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway

Yuelan Wu, Wenbo Geng, Qinjin Dai, Wanyun Zhang, Yuxian Lai, Pei Zhang, Chunjiang Zhou, Yinuo Wang, Qingfeng Cao, Xiang Luo, Yujie Lai, Changwei Huang und 1 weitere

Advanced Science · 2026

DOI: 10.1002/advs.76813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuelan Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory For the Prevention and Treatmen…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Uveitis, Nucleotidyltransferases, Dexamethasone. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation Key Program, National Natural Science Foundation of China, Chongqing Science and Technology Bureau Mountaineering Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune uveitis is a sight‐threatening inflammatory disease in which the cGAS‐STING signaling pathway exacerbates inflammation by recognizing excessive cell‐free DNA (cfDNA). However, conventional cfDNA scavengers have limited blood‐retinal barrier penetration, and monotherapies cannot control the complex inflammatory network. Herein, we developed a cationic poly(disulfide)‐drug nanoplatform (LA/DexP), which self‐assembled via salt bridge interactions and aggregation‐induced polymerization between a guanidyl‐functionalized lipoic acid derivative (LA) and dexamethasone phosphate (DexP). This platform is designed to synergistically inhibit the cGAS‐STING pathway and achieve efficient intraocular drug delivery. LA/DexP functioned as an efficient scavenger of cfDNA through electrostatic interaction, thereby inhibiting cGAS‐STING overactivation. Meanwhile, it leveraged thiol‐disulfide exchange to enhance blood‐retinal barrier penetration, achieving a 5.09‐fold higher apparent permeability coefficient than free DexP, and exhibited ROS‐responsive drug release. In an experimental autoimmune uveitis mouse model, LA/DexP treatment significantly reduced cfDNA levels and inhibited cGAS‐STING signaling. It also downregulated pro‐inflammatory cytokine expression, promoted macrophage polarization from the pro‐inflammatory M1 to the anti‐inflammatory M2 phenotype, and rebalanced Th1/Th17‐Treg cell subsets. These combined effects effectively inhibited uveitis severity. In summary, this study establishes a highly barrier‐permeable nanoplatform that synergistically integrates drug delivery with cGAS‐STING pathway inhibition, offering a promising therapeutic strategy for autoimmune uveitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesUveitisNucleotidyltransferasesDexamethasoneDisulfidesMembrane ProteinsAnimalscGAS-STING Signaling PathwayMiceDisease Models, AnimalCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseNanoparticlesSignal TransductionSTING Protein

Stichwörter der Autor:innen

autoimmune uveitiscGAS‐STING pathwaycell‐free DNAdrug deliveryhigh permeability

Substanzen

NucleotidyltransferasesDexamethasoneCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDisulfidesMembrane ProteinscGAS protein, mouseSTING Protein

Autor:innen und Institutionen

  • Ophthalmology Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory For the Prevention and Treatment of Major Blinding Eye Diseases, Chongqing Branch (Municipality Divis…
  • Department of Ophthalmology, Joint Research Laboratory For Ocular Immunology and Retinal Injury Repair, The First Affiliated Hospital of Zhengzhou University, Henan International, Henan Province Eye Hospital, Zhengzhou,…

ORCID-Profile: Peizeng Yang

Förderung

  • National Natural Science Foundation Key Program
  • National Natural Science Foundation of China
  • Chongqing Science and Technology Bureau Mountaineering Project
  • Science and Technology Cooperation Project of the First Affiliated Hospital of Zhengzhou University
  • China Postdoctoral Science Foundation
  • Postdoctoral Fellowship Program of the China Postdoctoral Science Foundation
  • Chongqing Medical Youth Top-notch Talent Project

Zitieren

APA

Wu, Y., Geng, W., Dai, Q., Zhang, W., Lai, Y., Zhang, P., Zhou, C., Wang, Y., Cao, Q., Luo, X., Lai, Y., Huang, C., & Yang, P. (2026). An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway. Advanced Science. https://doi.org/10.1002/advs.76813

Vancouver

Wu Y, Geng W, Dai Q, Zhang W, Lai Y, Zhang P, et al. An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway. Advanced Science. 2026. doi:10.1002/advs.76813

BibTeX
@article{Wu2026,
  author = {Wu, Yuelan and Geng, Wenbo and Dai, Qinjin and Zhang, Wanyun and Lai, Yuxian and Zhang, Pei and Zhou, Chunjiang and Wang, Yinuo and Cao, Qingfeng and Luo, Xiang and Lai, Yujie and Huang, Changwei and Yang, Peizeng},
  title = {An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76813}
}
Kostenlos starten →